Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 19  •  04:00PM ET
24.23
Dollar change
+1.04
Percentage change
4.48
%
IndexRUT P/E31.28 EPS (ttm)0.77 Insider Own3.81% Shs Outstand22.34M Perf Week-1.46%
Market Cap541.19M Forward P/E23.75 EPS next Y1.02 Insider Trans-0.90% Shs Float21.48M Perf Month64.16%
Enterprise Value491.95M PEG1.38 EPS next Q0.44 Inst Own93.26% Short Float8.55% Perf Quarter90.79%
Income18.17M P/S1.74 EPS this Y13.57% Inst Trans3.53% Short Ratio5.80 Perf Half Y145.99%
Sales311.51M P/B2.64 EPS next Y28.30% ROA6.64% Short Interest1.84M Perf YTD41.45%
Book/sh9.18 P/C8.20 EPS next 5Y22.60% ROE8.80% 52W High25.42 -4.66% Perf Year54.73%
Cash/sh2.95 P/FCF13.69 EPS past 3/5Y- 4.69% ROIC8.31% 52W Low8.61 181.42% Perf 3Y186.75%
Dividend Est.- EV/EBITDA16.54 Sales past 3/5Y12.09% 9.11% Gross Margin74.16% Volatility4.10% 4.95% Perf 5Y-36.55%
Dividend TTM- EV/Sales1.58 EPS Y/Y TTM21.00% Oper. Margin7.39% ATR (14)1.12 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.20 Sales Y/Y TTM9.28% Profit Margin5.83% RSI (14)75.83 Recom1.80
Dividend Gr. 3/5Y- - Current Ratio3.61 EPS Q/Q71.58% SMA2018.16% Beta0.77 Target Price24.00
Payout0.00% Debt/Eq0.08 Sales Q/Q17.32% SMA5044.65% Rel Volume1.99 Prev Close23.19
Employees1037 LT Debt/Eq0.07 EarningsNov 03 AMC SMA20080.75% Avg Volume316.73K Price24.23
IPOJul 28, 2016 Option/ShortYes / Yes EPS/Sales Surpr.114.41% 8.14% Trades Volume631,503 Change4.48%
Date Action Analyst Rating Change Price Target Change
Nov-04-25Upgrade BTIG Research Neutral → Buy $28
Oct-03-25Initiated Lake Street Buy $23.50
May-06-25Downgrade Piper Sandler Overweight → Neutral $14
Feb-19-25Downgrade B. Riley Securities Buy → Neutral $23 → $18
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Aug-07-19Upgrade BTIG Research Neutral → Buy $62
Nov-19-25 10:00AM
09:27AM
05:01AM
Nov-18-25 04:05PM
Nov-13-25 12:00PM
06:27AM Loading…
Nov-11-25 06:27AM
Nov-05-25 09:40AM
Nov-04-25 12:04AM
Nov-03-25 05:50PM
04:48PM
04:05PM
Oct-31-25 09:31AM
Oct-30-25 05:40PM
Oct-29-25 05:55PM
Oct-28-25 04:05PM
04:05PM Loading…
Oct-20-25 04:05PM
Sep-24-25 09:40AM
Sep-08-25 04:59PM
04:34PM
Aug-22-25 09:40AM
Aug-06-25 09:40AM
09:35AM
09:30AM
Aug-05-25 03:05AM
Aug-04-25 05:35PM
04:35PM
04:05PM
Jul-30-25 05:15PM
Jul-21-25 04:05PM
Jul-14-25 07:23AM
08:00AM Loading…
Jun-03-25 08:00AM
May-20-25 04:05PM
May-06-25 12:09PM
03:08AM
May-05-25 05:30PM
04:27PM
04:05PM
May-02-25 09:33AM
Apr-30-25 05:50PM
Apr-21-25 04:05PM
Apr-07-25 12:58PM
Mar-05-25 04:05PM
Feb-19-25 11:23AM
02:06AM
Feb-18-25 07:20PM
06:17PM
04:05PM
02:52AM
Feb-05-25 04:05PM
Feb-04-25 08:00AM
Jan-13-25 08:00AM
Jan-01-25 09:40AM
Dec-16-24 03:34PM
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
05:11PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
May-07-24 10:48AM
07:04AM
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
Apr-15-24 04:05PM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dodd Sheri LouiseChief Executive OfficerAug 08 '25Sale12.367,76295,907173,479Aug 12 06:03 PM
Dodd Sheri LouiseOfficerAug 08 '25Proposed Sale12.367,76295,906Aug 08 03:40 PM
Birkemeyer Elaine M.Chief Financial OfficerMay 12 '25Sale9.942,92129,03799,111May 14 05:26 PM
Birkemeyer Elaine M.OfficerMay 12 '25Proposed Sale9.942,92129,037May 12 05:25 PM
Dodd Sheri LouiseChief Executive OfficerMay 08 '25Sale9.833,14930,955181,241May 12 04:34 PM
BURKE WILLIAM WDirectorMay 08 '25Sale9.673,30031,91148,520May 09 04:28 PM
Dodd Sheri LouiseDirectorMay 08 '25Proposed Sale9.833,14930,955May 08 07:17 PM
BURKE WILLIAM WDirectorMay 08 '25Proposed Sale9.673,30031,911May 08 04:46 PM
Ferstler Sherri LeeOfficerApr 03 '25Proposed Sale13.142,35530,945Apr 03 05:30 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 25 '25Sale14.512,06629,980102,032Feb 27 04:29 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 25 '25Sale14.406,46893,16077,540Feb 27 04:28 PM
REUVERS DANIEL L.DirectorFeb 25 '25Sale14.1828,338401,850214,604Feb 27 04:27 PM
REUVERS DANIEL L.OfficerFeb 25 '25Proposed Sale14.1828,338401,851Feb 25 07:35 PM
Burns KristieOfficerFeb 25 '25Proposed Sale14.406,46893,160Feb 25 07:15 PM
Birkemeyer Elaine M.OfficerFeb 25 '25Proposed Sale14.512,06629,980Feb 25 06:54 PM
REUVERS DANIEL L.DirectorFeb 24 '25Sale14.5510,938159,147242,942Feb 24 06:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 24 '25Sale14.654,83070,75384,008Feb 24 06:23 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 24 '25Sale14.703,77855,538104,098Feb 24 06:22 PM
REUVERS DANIEL L.OfficerFeb 24 '25Proposed Sale14.5510,938159,147Feb 24 05:23 PM
Burns KristieOfficerFeb 24 '25Proposed Sale14.654,83070,753Feb 24 05:12 PM
Ferstler Sherri LeeOfficerFeb 24 '25Proposed Sale14.792,20932,660Feb 24 04:58 PM
Birkemeyer Elaine M.OfficerFeb 24 '25Proposed Sale14.703,77855,538Feb 24 04:55 PM